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Abstract
Smoking cigarettes is the leading cause of preventable death in the United States. Menthol is
well known to exacerbate tobacco addiction. It is unclear, however, if menthol directly effects
dopamine release which may increase the reward associated with smoking or if menthol has any
effect on environmental cues which act as reinforcers for smoking behavior. Study 1 used fast
scan cyclic voltammetry to examine the effects of nicotine and menthol, administered alone and
in combination, on phasic dopamine release in the nucleus accumbens of male Sprague-Dawley
rats. Results confirmed that nicotine, but not menthol, enhances phasic dopamine release in the
nucleus accumbens. Menthol added to nicotine did not enhance phasic dopamine release above
that elicited by nicotine alone. Study 2 used an online survey to examine the relationship
between menthol status and environmental cues on nicotine consumption in human smokers.
Results determined that there is no significant relationship between menthol status and smoking
behavior. Taken together these results suggest that nicotine is the driving force behind tobacco
addiction and menthol may act as a facilitator to make nicotine consumption more appealing.

Keywords: addiction, environmental cues, menthol, nicotine
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Smoking Behavior: An Analysis of Menthol's Effect on Nicotine
Smoking tobacco cigarettes is the leading cause of preventable death in the United States
(Biswas et al., 2016). Nicotine is the primary psychoactive and addictive component in tobacco
cigarettes and is a powerful reinforcer in both animals and humans (Ahijevych & Garrett, 2010;
Wickham, 2015). Mentholated cigarettes have been shown to have greater addictive potential
and are correlated with a lower quit rate than that associated with nonmenthol cigarettes (Fait et
al., 2017; Henderson et al., 2017; Wickham, 2019).
Nicotine
Nicotine is inherently rewarding and has positive reinforcing effects which increase the
probability of self-administration in animals, as well as negative reinforcing effects that relieve
negative symptoms associated with withdrawal (Ikemoto & Bonci, 2014; Valentine & Sofuoglu,
2018). Nicotine is a nicotinic acetylcholine receptor (nAChR) agonist that binds to nAChRs,
facilitating the release of dopamine (DA) from the ventral tegmental area (VTA) to the nucleus
accumbens (NAc) (Benowitz, 2009; Ikemoto & Bonci, 2014). nAChRs are comprised of five
subunits with the most abundant receptor subtypes in the mammalian brain being α4β2, α3β4,
and α7 (Benowitz, 2009). The rapidly desensitizing α4β2 and α6β2, and slowly desensitizing
α4α6β2 and α7 nAChR subtypes are believed to be the main mediating receptors in nicotine
dependence (Benowitz, 2009; Picciotto et al., 2008).
Smoking is the fastest route of administration, when a drug is inhaled it enters circulation
rapidly and reaches the brain within seconds (Benowitz, 2009). Increased rates of absorption and
drug entry into the brain are correlated with a greater “rush” and consequently the drug is more
reinforcing (Benowitz, 2009). Nicotine is metabolized into cotinine in the liver by the enzyme
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CYP2A6, cotinine has a longer half-life than nicotine and both are used as quantitative markers
for nicotine exposure (Benowitz, 2009).
Menthol
Menthol is a naturally occurring cyclic monoterpene alcohol that has a pleasant mint
flavor and creates a cooling sensation via transient receptor potential melanostatin 8 (TRPM8)
receptors which masks the aversive taste of nicotine and provides relief from the irritation
associated with inhaling tobacco smoke (Hans et al., 2012; Kamatou et al., 2013; Lehr et al.,
2021; Wickham, 2019). Menthol has two potential stereoisomers depending on the method of
production, (-)-menthol and (+)-menthol, however, (-)-menthol appears to be more relevant for
nicotine abuse because chronic exposure to (-)-menthol upregulates nAChR expression and
increases DA neuron excitability whereas (+)-menthol exhibits no such effect (Henderson et al.,
2019). With this in mind, a recent study comparing these stereoisomers of menthol found that (-)
-menthol and (+)-menthol may both effectively contribute to menthol-dependent exacerbation of
tobacco dependence (Lehr et al., 2021).
Menthol is a common flavorant in chewing gum and oral care products, and has been an
additive in cigarettes since the 1920s (Ahijevych & Garrett, 2010; Anderson, 2011; Kamatou et
al., 2013). Even cigarettes that are not labeled as menthols contain small amounts of menthol (Ai
et al., 2016; Anderson, 2011; DeVito et al., 2016; Fait et al., 2017; Kamatou et al., 2013; Lee &
Glantz, 2011). Cigarettes marketed as mentholated products contain a range between 2.9 – 19.6
mg menthol/cigarette, while cigarettes marketed as nonmentholated products contain 1.8 – 73.5
µg menthol/cigarette (Ai et al., 2016; Harrison et al., 2017).
Nicotine and Menthol Interactions
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Menthol exposure increases nicotine self-administration and produces a leftward shift of
the inverted-U of nicotine’s dose response curve, this facilitating effect of menthol on nicotine
self-administration is dose dependent (Biswas et al., 2016). Menthol also widens the doseresponse curve for nicotine’s euphoric and addictive effects, indicating nicotine is the driving
force behind addictive behaviors and menthol can act as a motivator for continued nicotine use
(Wickham, 2019). Menthol sustains and reinstates nicotine seeking behavior in rats, independent
of TRPM8 receptor activity (Biswas et al., 2016; Harrison et al., 2017). This suggests that
menthol, labeled or unlabeled, in most tobacco products could potentially contribute to the high
rates of continued use of and relapse to tobacco, though acute exposure to menthol has not been
shown to alter nicotine sensitivity (Valentine et al., 2018). Menthol also enhances the rewarding
effect of nicotine and may directly facilitate nicotine consumption (Biswas et al., 2016;
Wickham, 2019).
Conversely, long term menthol treatment before nicotine exposure decreases nicotine
reward-related behavior and the interactions between nicotine and menthol reduce nicotine’s
reinforcing and positive subjective effects (Henderson et al., 2016; Valentine et al., 2018).
Extended exposure to nicotine before exposure to menthol may elicit different interactions
between nicotine and menthol because acquisition did not occur simultaneously. This could
explain why Nesil and colleagues (2019) found that menthol decreased nicotine reward in their
study involving rats that were trained to lever press for nicotine alone before they were separated
into test groups, some of which received no nicotine during testing. This indicates that nicotine
and menthol may have different effects when present in the blood stream individually compared
to the effects that are present when combined.
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Nicotine menthol interactions indicate that reduced concentrations of nicotine in
cigarettes increases smoking cessation more in nonmenthol smokers than menthol smokers, and
menthol smokers experience stronger cravings than nonmentholated smokers (Denlinger-Apte et
al., 2019; Fait et al., 2017). Menthol smokers also have a reduced likelihood of successful
smoking cessation, and relapse rate is more common with female African American menthol
smokers (Smith et al., 2014).
Sensory Effects
Menthol cigarettes have a characteristic cool minty taste which can make them more
appealing than nonmentholated cigarettes (Ahijevych & Garrett, 2010). This may enable menthol
to facilitate smoking initiation by providing positive early smoking experiences and the minty
taste of menthol may contribute as a reinforcer for smoking behavior (Ahijevych & Garrett,
2010).
Menthol can have an analgesic effect whereby it alleviates the irritation in the throat and
lungs of first-time smokers, this can lead someone who was merely experimenting with smoking
to develop a habit because they do not experience the negative side effects commonly associated
with nonmentholated cigarettes (Anderson, 2011; Fait et al, 2017; Lehr et al., 2021). Smoke
intake in established smokers may be affected by cigarette mentholation, specifically menthol
smokers appear to have higher levels of smoke inhalation than nonmenthol smokers, and
menthol also decreases oral nicotine aversion in mice and is correlated with taste and flavor
association in human smokers (Fan et al, 2016; Strasser et al., 2013; Watson et al., 2017).
The amount of menthol necessary to begin having slight sensory effects is 0.6 – 1.5 mg
menthol/cigarette (Ai et al., 2016). Menthol masks the negative short-term physiological effects
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of smoking including throat pain, burning, and cough which provides superficial relief to
smokers; however, menthol does not reduce the stinging sensation produced by nicotine in the
nose (Anderson, 2011; Renner et al., 2012). Menthol dramatically enhances pharmacological
effects of nicotine including decrease in body temperature and analgesia and can act as a
counterirritant directly at nAChRs (Alsharari et al., 2015; Hans et al., 2012).
Systemic Effects
Menthol smokers have poorer smoking outcomes, as well as higher expression of
nAChRs in the VTA and other reward-related areas than nonmenthol smokers (Brody et al.,
2013; Wickham, 2015). Thus, menthol may influence neural responses to nicotine and may play
a role in the poorer cessation outcomes menthol smokers experience. Chronic exposure of
nicotine and menthol in combination significantly promotes α4β2 nAChR expression in the
hippocampus, striatum, and prefrontal cortex of mice, and chronic exposure to menthol alone
causes upregulation of these nAChR subtypes in the same brain regions (Alsharari et al., 2015).
Chronic nicotine exposure results in increased amounts of nAChRs with a higher affinity for
nicotine which leads to changes in reward-related DA release (Henderson et al., 2016). Acute
menthol exposure, however, has no effect on nAChR function (Henderson et al., 2016).
Chronic menthol exposure stabilizes lower sensitivity nAChRs and produces
upregulation of midbrain α4* nAChRs on VTA DA neurons which may partially negate
nicotine’s increased phasic DA release (Henderson et al., 2016). Menthol and nicotine in
combination produce a significant increase of α4α6β2 nAChRs in the midbrain which is
correlated with increased frequency of DA-neuron firing and enhancement of reward related
behavior (Henderson et al., 2017). When paired with nicotine, menthol attenuates α3β4 nAChRs
in humans through augmented desensitization which has important implications for menthols’
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analgesic effects in sensory nerves and may blunt or delay symptoms of nicotine withdrawal
(Ton et al., 2015).
Menthol is associated with increased nicotine to cotinine metabolic conversion and
inhibits nicotine absorption which could lead to subsequent higher consumption of mentholated
cigarettes to achieve the same level of nicotine exposure (Abobo et al., 2011). Menthol smokers
also have slower nicotine clearance than nonmenthol smokers which suggests an overall greater
exposure to nicotine per cigarette (DeVito et al., 2016). Menthol has an inhibitory effect on
nicotine metabolism which is associated with lower urges to smoke and less severe withdrawal
symptoms because nicotine remains unmetabolized in the blood stream and can interact with
more nAChRs which results in greater desensitization and more DA release (Benowitz et al.,
2009; Valentine et al., 2018).
This inhibition of nicotine metabolism could be a possible explanation for the decreased
nicotine infusion seeking seen in preclinical studies. Menthol exposed subjects may have less of
an incentive to receive more nicotine infusions since there is a greater amount of nicotine in their
blood stream compared to nonmenthol exposed subjects that would require more nicotine
infusions to attain an equivalent amount of nicotine in the blood stream. When undergoing
forced abstinence, menthol smokers also experience less alleviation of short-term abstinenceinduced craving than nonmenthol smokers when given intravenous injections of nicotine
(DeVito et al., 2016).
Dopamine Release and Nicotine Induced Reward
The mesolimbic DA system, extending from the VTA to the NAc, influences goal
directed behaviors, and nicotine augments preexisting goal directed behaviors (Grimm et al.,
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2012; Wickham et al., 2014). DA release results in a pleasurable feeling and is vital to the
reinforcing effects of drugs of abuse including nicotine (Benowitz, 2009; Grieder et al., 2019).
During tonic, baseline, firing, very little DA is released, however, phasic firing, where high rates
of neuron firing occur, there is increased DA release which is typically caused by the activation
of excitatory inputs to DA neurons (Picciotto et al., 2008).
Acute nicotine exposure elevates DA release in the NAc and hippocampus (Grimm et al.,
2012). Chronic use of nicotine and menthol in combination significantly increases DA levels in
the NAc and produces greater reward-related behavior compared to nicotine alone (Henderson et
al., 2017; Wickham, 2019; Zhang et al., 2018).
In the aftermath of long-term exposure to nicotine, α4* nAChRs, and sometimes α6*
nAChRs, upregulate and exhibit an increased sensitivity to nicotine (Akers et al., 2020). nAChRs
on GABA neurons are rapidly desensitized due to their increased sensitivity to nicotine and this
desensitization results in the disinhibition of VTA DA neurons and subsequently there is an
increase in DA neurotransmission within the mesolimbic pathway (Akers et al., 2020).
Excitatory inputs from medial VTA glutamate neurons, where α7 nAChRs are located, are also
enhanced, and the combined changes in the inhibitory and excitatory transmission contributes to
nicotine induced reward (Akers et al., 2020; Picciotto et al., 2008). β2* nAChRs in the VTA are
necessary for GABA and dopaminergic signaling for reward and aversion respectively (Grieder
et al., 2019) (see Figure 1).
Figure 1
Baseline Firing of Nicotinic Acetylcholine Receptors
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Note. Figure 1a shows DA firing before nAChR desensitization. The DA neuron receives
excitatory input from β2* receptor activation on the DA neuron itself, as well as α7 receptor
activation on glutamate neurons, and the DA neuron receives inhibitory input from β2* receptor
activation on GABA neurons. Tonic and phasic firing both occur before nAChR desensitization.
(Picciotto et al., 2008)
Firing of Nicotine Acetylcholine Receptors after Extended Nicotine Exposure
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Note. Figure 1b shows DA firing after extended exposure to nicotine. β2* nAChRs are
desensitized so there is no longer excitatory input from β2* receptor activation on the DA neuron
itself and there is no longer inhibitory input from β2* receptor activation on the GABA neuron.
DA release is still sustained due to the continued activation of excitatory input from α7 receptor
activation on glutamate neurons since α7 nAChRs desensitize much slower than β2* nAChRs.
(Picciotto et al., 2008).
Environmental Cues
Environmental cues are external stimuli associated with a certain behavior, such as drug
use (Perry et al., 2014). Drug associated cues are important contributors to the effects of the
associated drug and can also evoke drug seeking in times of abstinence (Palmatier & Bevins,
2008). These cues also increase DA release in the NAc and are acquired through conditioned
reinforcement (Perry et al., 2014; Wickham et al., 2013). Desensitization of nAChRs may
enhance responses to and increase the salience of environmental cues that are paired with
smoking (Brunzell & Picciotto, 2009). Cues that predict the administration of a reward evoke an
increase in phasic DA firing to a greater degree than the expected rewards themselves (Day et al.,
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2010). Higher phasic:tonic DA firing ratios, such as those present when nicotine is in the brain,
make cues more salient and easier to associate with smoking (Picciotto et al., 2008).
Cues can produce withdrawal symptoms independent of their associated drug in both
humans and animals (Perry et al, 2014). Contextual cues are environmental stimuli that are not
directly related to the drug taking behavior, but are present in the background of drug taking
activities and are therefore important mediators of drug-seeking behavior because the
environment has become associated with drug taking (Perry et al., 2014).
Smokers who experience simultaneous cues such as being in a smoking environment and
seeing cigarettes burning in an ashtray experience cue-induced craving and increased smoking
behavior (Conklin et al., 2019). Conditioned reinforcers such as flavorants, notably menthol, can
act as orosensory cues which are important for the self-administration of tobacco products in
humans (Palmatier et al., 2020; Wang et al., 2014; Wickham, 2019). Menthol can have an
occasion setting effect wherein the presence of menthol can act as a cue for nicotine selfadministration, independent of TRPM8 receptor activity (Harrison et al., 2017).
Smoking Demographics
Sex and age dependent factors may underlie the influence of menthol on nicotine intake.
Fait and colleagues (2017) found that adult male mice significantly increased nicotine intake
when it was paired with menthol, whereas adult female mice did not show this preference. The
adult male mice in this study also exhibited decreased locomotion whereas this behavioral
response to menthol was not observed in any of the adolescent mice. Ross and colleagues (2016)
found that, in human smokers, puff characteristics of individual cigarettes are indicative of daily
nicotine intake and factors including sex and menthol status were significant predictors of daily
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nicotine exposure. African Americans, females, lower socioeconomic status individuals, and
adolescents are more likely to use mentholated cigarettes (Ahijevych & Garrett, 2010; Foulds et
al., 2010; Ross et al., 2016; Wickham, 2015; Wickham, 2019). Among menthol smokers, young
adults and members of the LGBTQIA+ community are less likely to have an intention to quit
smoking (Smiley, 2018).
Marketing for menthol cigarettes has historically targeted African Americans, women,
and young populations (Lee & Glantz, 2011; Smith et al., 2020; Wickham, 2019). Younger
populations may be drawn to menthol cigarettes and this may result in menthol cigarettes acting
as a “starter product” which can lead to the development of a smoking habit (Ahijevych &
Garrett, 2010; Lee & Glantz, 2011). Menthol smokers who are young and in a racial or ethnic
minority have a lower quit rate than nonmenthol smokers (Ahijevych & Garrett, 2010; Foulds et
al., 2010).
The Present Studies
The purpose of Study 1 was to examine if menthol alone alters phasic DA release given
that menthol can influence nicotine receptor expression. Furthermore, this study examined
whether menthol could influence nicotine’s ability to drive DA release. The first hypothesis was
that nicotine alone would significantly increase DA release relative to baseline, given that
previous studies have shown similar results (Picciotto et al., 2008). The second hypothesis was
that menthol alone would not increase DA levels relative to baseline given that acute menthol
has no effect on nAChR function (Henderson et al., 2016). And the third hypothesis was that
when combined with nicotine menthol would have an additive effect on DA release in the NAc
relative to baseline, given that menthol increases nicotine self-administration in preclinical
studies and widens the dose response curve of nicotine (Biswas et al., 2016; Wickham, 2019).
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Cues are potent drivers of relapse to drugs, and menthol can act as a cue as well as
enhance the rewarding value of other nicotine paired cues (Wickham, 2019). Study 2 aimed to
examine if menthol increases nicotine's effect on the salience of environmental cues in human
smokers. More specifically, it was hypothesized that menthol smokers would have stronger urges
to smoke associated with environmental cues, menthol smokers would have a more difficult time
quitting than nonmenthol smokers, and that menthol smokers would be more likely to use a
smoking cessation tool than nonmenthol smokers.
Study 1
Methods
Subjects
Twenty male Sprague-Dawley rats (250-300g) from Charles River Laboratories were
housed 2 to 3 per cage and provided ad libitum food and water on a 12-hour light/dark cycle
beginning at 7 am. Four subjects were removed from analysis due to unreliable data recordings
and an additional subject was removed from analysis due to insufficient data collection. All
experiments were conducted according to the Guide for the Care and Use of Laboratory Animals
and were approved by the Yale University Institutional Animal Care and Use Committee.
Surgery
Four small holes were drilled into the skulls of anesthetized rats for the insertion of a
bipolar stimulator retrofitted with a cannula, a carbon microfiber electrode, a reference wire, and
a screw to secure the reference electrode. Anteroposterior (AP), mediolateral (ML), and
dorsoventral (DV) coordinates were referenced from bregma. A bipolar, stainless steel
stimulating electrode was inserted into the VTA (AP −5.2 mm, ML 0.5-1.5 mm, DV from 7.4 to
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8.1 mm below dura). An Ag/AgCl reference electrode was inserted into the contralateral cortex
and was held with a screw attached to the skull to minimize the number of manipulators used.
The pia matter was punctured and removed, and a carbon-fiber microelectrode was implanted
vertically in the NAc core (AP +1.2 mm, ML −1.4 mm, DV from 6.2 to 6.9 mm) (see Figure 2).
Figure 2
Placement of Stimulating and Recording Electrodes in Rat Brains

Note. The stimulating electrode (black) was placed in the VTA to stimulate the release of DA in
anesthetized rats and the recording electrode (white) was placed in the NAc to record DA release
(Kauer & Malenka, 2007).
Fast-Scan Cyclic Voltammetry (FSCV)
Electrical stimulation (300µA, 60Hz, 24 pulses) was applied to the VTA using a bipolar
electrode to evoke phasic DA release in the NAc core of the anesthetized subjects. Each
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stimulation was applied every 3 minutes so DA releasable stores could return to their original
levels.
FSCV is a method of examining neurotransmitter signaling within the brain that provides
high chemical selectivity and temporal resolution (Wickham et al., 2014). During FSCV current
is generated at different potentials and the redox reactions for different neurotransmitters are
recorded and displayed with distinct peaks for oxidation and reduction (Wickham et al., 2014).
Dopamine is absorbed onto the FSCV carbon microfiber electrode and the electrode records the
oxidation of DA into DA-orthoquinone and the subsequent reduction of DA-orthoquinone into
DA (see Figure 3).
Figure 3
The Methodology of Fast-Scan Cyclic Voltammetry

Note. DA is absorbed onto the carbon fiber microelectrode, at 0.6V DA is oxidized into DAorthoquinone and at -0.2V reduced back into DA, voltage is cycled every 100ms (Foster, 2014).
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Experimental Design and Data Analysis
Six baseline recordings of DA release were recorded from each subject. Intraperitoneal
(IP) injections of nicotine (n = 8, 0.35mg/kg in 0.09% saline) or menthol (n = 7, 400mg/kg in 5%
DMSO, 45% Tween, and 50% vehicle) were then administered and DA measurements continued
for 30 minutes. In five rats that received IP nicotine injections, IP menthol injections were
administered 30 minutes later, and DA measurements were collected for an additional 30
minutes.
All FSCV recordings were converted to percent baseline for analysis. A one-way
Analysis of Variance (ANOVA) was conducted to analyze the effect of time on each drug
condition. A two-way within subjects ANOVA was conducted to analyze the effects of menthol
when nicotine was already in the system, and a two-way mixed-model ANOVA was conducted
to analyze the effects of nicotine versus menthol over time.
Results
A one-way ANOVA revealed that there was a significant effect of time on nicotine
exposure alone, F(15, 105) = 2.056, p = 0.018. Bonferroni’s post-hoc test showed significance
from baseline to six minutes post-injection, p = 0.0034 (see Figure 4). A one-way ANOVA
revealed that there was no significant effect of time on menthol exposure alone F(15, 90) =
1.581, p = 0.095 or nicotine and menthol exposure combined F(12, 48) = 1.270, p = 0.267.
A two-way within subjects ANOVA on nicotine and menthol in combination revealed
that there was no significant effect of time F(12, 48) = 0.547, p = 0.872, drug F(1, 4) = 0.611, p
= 0.478, or time x drug F(12, 48) = 1.304, p = 0.248. A two-way between subjects ANOVA on
nicotine alone and menthol alone revealed that there was no significant effect of time F(15, 195)
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= 1.061, p = 0.396, however, there was a significant effect of drug F(1, 13) = 5.946, p = 0.030,
and there was a significant effect of time x drug F(15, 195) = 2.544, p = 0.002.
Figure 4
Effects of Nicotine and Menthol Exposure on Phasic Dopamine Release in the Nucleus
Accumbens

Note. Baseline recordings were taken before the administration of each drug condition: nicotine
(n = 8), menthol (n = 7), and nicotine and menthol (n = 5). DA levels were recorded for 30
minutes post drug exposure. After 30 minutes, menthol was administered to a subset of 5
subjects from the nicotine condition and the subsequent DA levels were recorded for an
additional 30 minutes and were compared to the last 3 DA recordings in the nicotine condition to
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examine any additive effects of menthol when nicotine is already present in the system. Data are
presented as the mean ± SEM. * = p < 0.05
Discussion
Study 1 explored whether acute menthol exposure could influence phasic DA release in
the NAc. The results of this study confirm that nicotine enhances phasic DA release in the NAc,
however, menthol alone does not increase DA release, nor does menthol have any additive
effects on DA release in conjunction with nicotine.
In the current literature, systemic changes in nAChR expression are found after exposure
to chronic menthol (Henderson et al., 2016; Henderson et al., 2017; Ton et al., 2015). While the
results did not indicate significant changes in DA levels in this study, this could be because acute
menthol exposure was utilized rather than chronic menthol exposure. It is possible that acute
menthol has no significant systemic reactions, but rather is more important for the acquisition of
nicotine consumption because of its ability to mask the aversive taste of nicotine and to coat the
lungs so smoke inhalation is more tolerable (Wickham, 2019).
Nicotine is the primary psychoactive ingredient in tobacco cigarettes, it produces
euphoric effects and is the driving force behind tobacco addiction (Wickham, 2015). Menthol
alone has no euphoric effects but is able to facilitate tobacco addiction through enhancing the
appeal of nicotine products and making them available to larger populations (Wickham, 2015). It
is possible that acute menthol exposure does not affect the rewarding properties of nicotine and
tobacco consumption and acute menthol exposure is instead more important for the initial
acquisition of smoking behavior.
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These data speak to acute effects of menthol and nicotine, not chronic effects of menthol
where many nAChR effects are observed. Keeping this in mind, one major limitation to Study 1
is the small sample size, most notably that only five rats received nicotine and then menthol to
examine potential additive effects. Future studies should examine menthol’s influence on DA
release in the NAc using at least ten rats per experimental condition and more conditions should
be examined to gain a better understanding for how menthol interacts with DA release alone and
in combination with nicotine. These conditions should include acute menthol exposure, acute
nicotine exposure, acute menthol exposure after acute nicotine exposure to examine any additive
effects, acute menthol and nicotine exposure simultaneously to examine combined effects, as
well as chronic effects of menthol and nicotine exposure with each condition.
These results imply that the role of menthol in nicotine and tobacco addiction is more
complex than simply increasing DA release, leading to a greater feeling of pleasure. Nicotine
produces rewarding behaviors through increased DA release, which implies that nicotine is the
driving force behind tobacco addiction. The role of menthol in tobacco addiction appears to be
more complex and requires further research to be fully understood.
Study 2
Study 2 compared smoking behavior and motivations between menthol and nonmenthol
preferring smokers. It was hypothesized that menthol smokers would have stronger urges to
smoke associated with environmental cues, more difficulty quitting, and be more likely to use a
smoking cessation tool than nonmenthol preferring smokers.
Methods
Participants
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One hundred participants, 42 menthol smokers and 58 nonmenthol smokers, completed a
five-minute online survey about their smoking preference and behavior. Data from three
respondents were removed from analysis because when asked “at what age did you begin using
nicotine products” they responded with “never.” Of the 100 respondents that were included in
analysis, 22 were 18-24, 15 were 25-39, 46 were 40-59, and 17 were 60+; 93 were White, 3 were
Black/African American, 1 was Latino/Hispanic, and 3 classified themselves as “other”; 75 were
female, 22 were male, and 3 were nonbinary; 2 had less than a high school degree, 20 had a high
school degree or equivalent, 5 had a trade school degree, 26 had some college but no degree, 9
had an Associate Degree, 23 had a Bachelor’s Degree, 13 had a Master’s Degree, and 2 had a
PhD or higher; 10 lived in an urban area, 31 lived in a suburban area, and 59 lived in a rural area;
58 grew up in a smoking household and 42 grew up in a nonsmoking household; and 7 believed
menthol cigarettes are less dangerous than nonmenthol cigarettes.
Participants were recruited from different social media platforms utilizing the snowball
effect method. One initial request was sent out, to take the survey if eligible or to share the
survey link, and participants were recruited through subsequent reposts of the initial request.
This study was approved by the Elizabethtown College Institutional Review Board in February
2021.
Design
Participants were asked to respond to yes/no, fill in the blank, and multiple-choice
questions to understand each individual’s background and smoking preference. These questions
included “have you smoked in the last 30 days?” (yes/no), “I prefer to smoke
___________(menthol/nonmenthol) cigarettes”, “Have you ever smoked mentholated
cigarettes?” (yes/no), “do you currently smoke tobacco on a daily basis, less than daily, or not at
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all?”, “have you smoked tobacco daily in the past?” (yes/no), “in the past, have you smoked
tobacco on a daily basis, less than daily, or not at all?”, “have you ever wanted to quit smoking?”
(yes/no), “have you ever attempted to quit smoking?” (yes/no), “have you ever successfully quit
smoking?” (yes/no), “how many times have you attempted to quit smoking?” (1-6+), “how many
times have you begun smoking again after attempting to quit?” (1-6+), “have you ever used a
smoking cessation tool (i.e. Chantix [Varenicline] or Zyban [Bupropion]) or nicotine
replacement therapy (i.e. nicotine patch, gum, spray, lozenge, inhaler, etc.)?” (smoking cessation
tool, nicotine replacement therapy, both, neither), and “during the past 12 months, have you tried
to stop smoking?” (yes/no).
Participants were then asked to respond to statements using a five-point Likert scale,
where 1 indicated strongly disagree, 2 indicated disagree, 3 indicated neutral, 4 indicated agree,
and 5 indicated strongly agree, in order to understand how environmental cues may impact the
smoking behaviors of each individual. Likert scale statements included: “when I am in a specific
environment, I feel a stronger urge to smoke”, “I feel the urge to smoke in inappropriate places”,
“I often feel the urge to smoke when I see a cigarette”, “I smoke to feel better”, “I smoke to feel
good”, “I smoke because I am bored”, “I smoke to relieve cravings”, “I smoke to relieve
withdrawal symptoms”, “I often feel the urge to smoke when I see an ashtray”, “I smoke without
thinking about it”, “Smoking feels like a habit”, “I often feel the urge to smoke when I see a
lighter”, and “I often smoke in the same location”; some of these questions were taken from a
scale used by Newton and colleagues (2009) to examine theories of addiction (Cronbach’s α =
898).
Demographics collected included current age, the age participants began using nicotine
products, race, gender, education level, community type, if the participant grew up in a smoking
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or nonsmoking household, and if the participant believes menthol cigarettes are less dangerous
than nonmentholated cigarettes.
An independent samples t-test was run to examine the relationship between menthol
status and environmental cues and to examine the relationship between menthol status and age of
acquisition, and chi-square test of association tests were run to examine the relationships
between menthol status and the frequency of nicotine consumption, successful quit rate,
utilization of smoking cessation tools, and demographics.
Results
An exploratory factor analysis revealed three main categories when examining the
relationship between menthol status and the reasons behind smoking behavior: emotion, urges,
and environment (see Table 1). An independent samples t-test revealed no significant difference
in emotion driving smoking behavior between menthol (M = 3.17, SD = 1.02) and nonmenthol
smokers (M = 2.94, SD = 1.24), t(98) = 0.994, p = 0.323, d = 0.201; no significant difference in
urges driving smoking behavior between menthol (M = 2.83, SD = 1.19) and nonmenthol
smokers (M = 3.05, SD = 1.33), t(98) = -0.868, p = 0.388, d = -0.176; and no significant
difference in environment driving smoking behavior between menthol (M = 1.68, SD = 0.999)
and nonmenthol smokers (M = 1.94, SD = 1.11), t(98) = -1.21, p = 0.230, d = -0.245 (see Figure
5). An independent samples t-test revealed no difference age of acquisition between menthol (M
= 16.6, SD = 3.72) and nonmenthol smokers (M = 16.6, SD = 5.48), t(97) = -0.0307, p = 0.976, d
= -0.00625 (see Figure 6).
Table 1
Exploratory Factor Analysis of the Variables Related to Smoking Behavior
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Factor Loadings
Factor
1
When I am in a specific environment, I feel a stronger urge to
smoke.

2

3

0.568

Uniqueness
0.6148

I feel the urge to smoke in inappropriate places.

0.6869

I often feel the urge to smoke when I see a cigarette.

0.4799

I smoke to feel better.

0.718

0.3612

I smoke to feel good.

0.895

0.2198

I smoke because I am bored.

0.616

0.3841

I smoke to relieve cravings.

0.607

0.4166

I smoke to relieve withdrawal symptoms.

0.619

0.4801

I often feel the urge to smoke when I see an ashtray.

0.719

0.3448

I smoke without thinking about it.

0.778

0.4323

Smoking feels like a habit.

0.641

0.4219

I often feel the urge to smoke when I see a lighter.

0.971

I often smoke in the same location.

0.0479
0.5945

Note. 'Minimum residual' extraction method was used in combination with an 'oblimin' rotation.
Factor loadings below 0.5 were excluded from analysis. Factor 1 indicates variables in the
Emotion category, Factor 2 indicates variables in the Urges category, and Factor 3 indicates
variables in the Environment category.
Figure 5
Independent Samples T-Test Examining the Motivation Behind Smoking Behavior
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Note. Higher numbers are indicative of stronger motivations to smoke. Data is displayed as mean
± SEM.
Figure 6
The Relationship of Menthol Status with Age of Acquisition

Note. Data is displayed at mean ± SEM.

26

Chi-square test of association were run to examine the relationship between menthol
status and smoking behavior. There was no relationship between menthol status and desire to
quit smoking, χ2 (1, N = 100) = 0.072, p = 0.788, Cramer’s V = 0.027 (see Figure 7). There was
no relationship between menthol status and successful quit rate, χ2 (1, N = 100) = 0.493, p =
0.483, Cramer’s V = 0.070 (see Figure 8). There was no relationship between menthol status and
number of attempts to quit smoking, χ2 (6, N = 100) = 4.15, p = 0.656, Cramer’s V = 0.204 (see
Figure 9a), or number of times relapsing after attempting to quit, χ2 (6, N = 100) = 2.43, p =
0.877, Cramer’s V = 0.156 (see Figure 9b). There was no relationship between menthol status
and utilization of a smoking cessation tool, χ2 (3, N = 100) = 1.50, p = 0.682, Cramer’s V =
0.123 (see Figure 10). There was no relationship between menthol status and smoking daily, χ2
(1, N = 100), p = 0.116, Cramer’s V = 0.157 (see Figure 11). There was no relationship between
menthol status and if participants believed menthol cigarettes are less dangerous than
nonmentholated cigarettes, χ2 (1, N = 100) = 0.00227, p = 0.962, Cramer’s V = 0.00476 (see
Figure 12).
Figure 7
Menthol Status Differences in Desire to Quit Smoking
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Note. Data is displayed as the mean of each group.
Figure 8
Menthol Status Differences in Successful Smoking Cessation

Note. Data is displayed as the mean of each group.
Figure 9
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Menthol Status Differences in Number of Attempts to Quit

Note. Figure 9a: Data is displayed as the mean of each group.
Menthol Status Differences in Number of Relapses

Note. Figure 9b: Data is displayed as the mean of each group.
Figure 10
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Menthol Status Differences in Use of a Smoking Cessation Tool

Note. Data is displayed as the mean of each group.
Figure 11
Menthol Status Differences in Smoking Daily

Note. Data is displayed as the mean of each group.
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Figure 12
Menthol Status Differences in Opinion on if Menthol Cigarettes are Less Dangerous than
Nonmenthol Cigarettes

Note. Data is displayed as the mean of each group.
Chi-square test of association were also run to compare menthol status within each
demographic collected. There was no relationship between menthol status and growing up in a
smoking or nonsmoking household, χ2 (1, N = 100) = 1.90, p = 0.168, Cramer’s V = 0.138 (see
Figure 13). There was no relationship between menthol status and type of area participants lived
in, χ2 (2, N = 100) = 0.610, p = 0.737, Cramer’s V = 0.078 (see Figure 14). There was no
relationship between menthol status and the highest level of education participants had
completed, χ2 (7, N = 100) = 13.9, p = 0.054, Cramer’s V = 0.372 (see Figure 15). There was no
relationship between menthol status and gender, χ2 (2, N = 100) = 2.72, p = 0.256, Cramer’s V =
0.165 (see Figure 16). There was no relationship between menthol status and race, χ2 (5, N =
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100) = 5.01, p = 0.415, Cramer’s V = 0.224 (see Figure 17). There was a relationship between
menthol status and age, χ2 (3, N = 100) = 21.7, p < .001, Cramer’s V = 0.466 (see Figure 18).
Figure 13
Menthol Status Differences in Household Environment Growing Up

Note. Data is displayed as the mean of each group.
Figure 14
Menthol Status Differences in Participant Living Location
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Note. Data is displayed as the mean of each group.
Figure 15
Menthol Status Differences in Level of Education

Note. Data is displayed as the mean of each group.
Figure 16
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Menthol Status Differences in Gender

Note. Data is displayed as the mean of each group.
Figure 17
Menthol Status Differences in Race

Note. Data is displayed as the mean of each group.
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Figure 18
Menthol Status Differences in Age

Note. There were significantly more nonmenthol smokers aged 40-59 than menthol smokers.
Data is displayed as the mean of each group. * = p < .001
Discussion
While the results from Study 2 do not support the hypothesis that menthol smokers would
have stronger associations with environmental cues and would have a more difficult time with
smoking cessation, these results do have interesting implications. Abstinence outcomes are
independent of menthol status which implies that menthol status does not affect the rate of
successful smoking cessation, although a recent meta-analysis from Smith and colleagues (2020)
indicates this may only be in Black populations (Jao et al., 2017). Pre-existing differences,
including biological differences, between menthol preferring and non-preferring smokers may
influence their perception of nicotine as well as their response to short term abstinence programs
(DeVito et al., 2016). This suggests that individual differences contribute more to successful
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smoking cessation than menthol status itself, and furthermore implies that there may be
biological reasons behind why an individual prefers mentholated cigarettes to nonmentholated
cigarettes and it may be those reasons, not the menthol itself, that leads to less success with
smoking cessation that is seen in established literature (DeVito et al., 2016; Fait et al., 2017;
Henderson et al., 2017; Wickham, 2019). It is possible that future research on this could lead to
enhancements in smoking cessation interventions.
Results did indicate that individuals who are 40-59 years old are more likely to smoke
nonmenthol cigarettes than menthol cigarettes. This makes sense within the current literature
because menthol cigarettes are marketed toward younger populations (Lee & Glantz, 2011).
Nicotine is reinforcing on its own. Menthol may not necessarily increase how reinforcing
nicotine is, but it can blunt the positive responses to nicotine and is correlated with less severe
nicotine withdrawal after overnight nicotine deprivation (Valentine et al., 2018). Lifetime
smokers exhibit no acute effects of menthol, which indicates that menthols’ effects appear to be
more long term in which the plasticity of the brain is altered via changes in nAChRs (Valentine
et al., 2018; Wickham, 2019). It is possible that there is a ceiling effect wherein the effects of
nicotine are so potent that menthol does not have the ability to create additive effects in
established smokers, similar to how there is a decline in cue reactivity of established smokers
due to a ceiling effect (Karelitz, 2020).
Keeping this in mind, it is important to address the limitations of this study. There are
limitations in the design of the online study. Most questions were not taken from a questionnaire
that has a known reliability, instead they were made by the author. Questions that target more
specific behavior of menthol versus nonmenthol preferring smokers could have been asked and
participants could have been directed to more specific questions depending on their responses to
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questions about their menthol status. Specifics should have been asked about environmental cues
as well, for example after each Likert scale question was answered there could have been a
follow up question asking participants to explain their responses, for example what specifically
makes them feel a stronger urge to smoke. The questions that were ultimately asked were general
in nature and it would have been interesting to see if there were any commonalities between
menthol status if participants were asked to elaborate for themselves.
Future studies should examine smoking behavior throughout the duration of an
individual’s time smoking cigarettes. Questions should examine motivation behind beginning to
smoke, current smoking behaviors, attitudes toward menthol and nicotine in general, and
intentions toward smoking cessation. I would also be interesting to conduct personal interviews
with participants to gather more information from participants in an open-ended manner. It is
possible that environmental cues related to smoking behavior may operate nonconsciously which
would mean participants could not report their reactions to these cues themselves. Instead, a
behavioral measure could be used to examine if this is the case. For a follow-up like this,
menthol and nonmenthol smokers would both experience the same cue, for example watching a
video of someone lighting a cigarette, and each participant would be asked to rate their craving
for a cigarette before and after the cue is administered. Overall, it is important to note that while
there was no difference in menthol status on efficacy of environmental cues or smoking
cessation, there could be underlying differences in menthol status that were not addressed with
this survey.
Conclusion
The results of Study 1 confirm that nicotine elevates phasic dopamine release in the
mesolimbic pathway, which aligns with the first hypothesis of the study. The second hypothesis,
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that menthol alone would have no significant effect on dopamine release, was also supported by
data from Study 1. The third hypothesis, that the addition of menthol would have an additive
effect on dopamine release elicited by nicotine, was not supported. Menthol had no additive
effect on dopamine release when nicotine was already present in the system. This is likely due to
the use of acute menthol exposure for Study 1, or due to the delay in administration of menthol
after nicotine. It is possible that there are effects that are dependent on when nicotine and
menthol are administered in relation to each other.
Results of Study 2 did not support the hypothesis that menthol smokers would have
stronger urges to smoke associated with environmental cues, a more difficult time quitting, and
be more likely to use a smoking cessation tool than nonmenthol smokers. The present results
indicate that there is no difference in menthol status on the salience of environmental cues acting
as motivation behind smoking behavior.
Taken together the results of Study 1 and Study 2 have interesting implications. Nicotine
is the addictive substance in tobacco cigarettes, not menthol, however, menthol can help
facilitate the acquisition of smoking because it makes the consumption of nicotine less aversive
by providing relief from smoke inhalation and masking the aversive taste associated with
nicotine (Wickham, 2019). The mechanisms behind the interaction between menthol and
nicotine are more complex than initially believed and future research should examine menthol
independently from nicotine, as well as combined, in several different conditions to examine
how DA release and nAChR expression are affected. Results from these preclinical studies can
be applied in human research to better understand how menthol status can affect nicotine
acquisition, continued use, and smoking cessation. The use of more specific survey questions
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geared toward understanding the motivations behind smoking behavior may yield a deeper
understanding of menthol’s role in the acquisition and continuations of nicotine use.
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